Jeffrey S. Lizano

Activation of Heterotrimeric G-protein Signaling by a Ras-related Protein

E. Duzic, M. Cismowski, C. Ribas, 2000, The Journal of Biological Chemistry.

In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.

D. Scott, D. Hargrove, R. L. Dow, 2010, Biochemical and biophysical research communications.

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.

D. Scott, P. Iredale, S. Sakya, 2006, Bioorganic & medicinal chemistry letters.

Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist

D. Scott, P. Iredale, Xingrong Liu, 2010, BMC pharmacology.

Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents.

D. Scott, P. Iredale, R. L. Dow, 2012, ACS medicinal chemistry letters.

Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling

E. Duzic, A. Takesono, M. Cismowski, 1999, Nature Biotechnology.